Is Canopy Growth (TSX:WEED) Stock the Best Pot Stock to Buy Now?

Here is why Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) stock is the best pot stock to own.

| More on:

After seeing the eye-popping gains in Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) stock this year, it’s a reasonable question to ask by investors: have they already missed the boat?

No doubt the rally in this largest marijuana producer has been stunning. After falling to around $40 a share in early January, Canopy Growth stock has rebounded strongly, gaining about 60% in the matter of just five weeks.

That level of ups and downs isn’t unusual in this highly unstable segment of the market, but there is a clear difference in the current momentum that we’re seeing in Canopy stock.

In my opinion, investors have realized that it’s relatively safe strategy to stick with the biggest and the best stocks in the fast-evolving pot industry. Let’s take the example of Aphria Inc. stock.

It went down so fast after a damning report by a short-seller late last year who raised questions about the company’s deal making in the overseas markets. The allegation destroyed the shareholders’ value and forced the company to look for a new CEO.

In my view, Canopy Growth is one marijuana stock where investors are relatively safe and are unlikely to see a big negative surprises. The reason behind this optimism is that the company is already ahead in the game and has been through a major scrutiny when Constellation Brands acquired a major stake in Canopy last year.

Canopy Growth stock: global expansion continues

What makes Canopy different from other producers is its market size, capacity to ramp up production, and diversity of product offerings, alongside its international reach. Canopy currently operates weed-growing facilities with over 2.4 million square feet of space.

But the producer has been expanding its operations quickly, which will deliver the potential to manage more than five million square feet of production space by next year.

In the latest development, Canopy Growth has formed a company with a U.K. researcher of cannabis-based therapies after the British government moved to liberalize the use of medical marijuana.

The new company, formed with Beckley Canopy Therapeutics Ltd., aims to make products available in Britain from early this year. The government made it legal for specialist doctors to prescribe medical marijuana for patients with severe clinical need in November.

Earlier, Canopy acquired a hemp licence in New York State as part of it plan to build an extraction and manufacturing facility. GMP analyst Martin Landry, who raised the stock price target to $70 from $50, said in a recent note that CBD-based consumer products could amount to a combined U.S. market size of $50 billion.

Bottom line

With the fast-paced global expansion and leading position in the Canadian market where recreational pot is now legal, Canopy Growth seems to be the safest best for the long-term investors seeking exposure in this area.   

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Haris Anwar has no position in the companies mentioned.

More on Investing

Business man on stock market financial trade indicator background.
Tech Stocks

1 Growth Stock Down 50 Percent to Buy Right Now

There are plenty of growth stocks in the market worth considering, but Shopify (TSX:SHOP) looks like one of the best…

Read more »

You Should Know This
Dividend Stocks

How to Convert a $300 Monthly Investment Into $338 in Monthly Income

If you want a certain amount in monthly passive income, invest a similar amount today and leave the rest to…

Read more »

Increasing yield
Dividend Stocks

3 Income Stocks With Big Yields to Consider in April 2024

If you haven’t yet made your March investments, here are three income stocks to buy the dip and lock in…

Read more »

Senior Man Sitting On Sofa At Home With Pet Labrador Dog
Dividend Stocks

RRSP Investors: Don’t Miss Out on This Contribution Hack!

This hack has so many benefits for you -- not just when you put it in your RRSP but for…

Read more »

edit Sale sign, value, discount
Stocks for Beginners

These 3 Growth Stocks Are on Sale and Set to Surge

Some growth stocks are on sale right now that offer massive long-term potential for investors. Here's a trio to consider…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Young woman sat at laptop by a window
Dividend Stocks

3 Dividend Stocks Everyone Should Own for the Long Haul

For investors looking for top-tier dividend stocks to buy and hold for the long term, here are three of my…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

Passive Income: 2 Safe Dividend Stocks to Own for the Next 10 Years

Dividend stocks such as Manulife and Fortis can help you generate a stable and recurring passive-income stream.

Read more »